MT-6548
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MT-6548, covering 2021-04-12 to 2021-07-06. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan [Phase 3]